Therefore, in bladder cancer, miR-20a may activate the MEK signaling pathway by inhibiting NR4A3, thereby promoting EMT and promoting the proliferation and metastasis of bladder cancer. This evidence concerns the gene MAP2K7 and urinary bladder cancer.